UM Guidelines
Liver Transplant

Inpatient and Surgical Care (ISC)

BCBST last reviewed November 12, 2020*

Added to Clinical Indications:
Model for end-stage liver disease (MELD) score 6 through 40


Updated contraindications:

No active alcohol or illicit substance use. A minimum three month abstinence period documented in medical record is required with a current negative drug and/or alcohol screen.


Referencesnload Acrobat Reader

  1. BlueCross BlueShield Association. Evidence Positioning System. (9:2019). Liver Transplant and combined liver-kidney transplant (7.03.06). Retrieved August 12, 2020 from (62 articles and/or guidelines reviewed)
  2. BlueCross BlueShield of Tennessee network physicians. September - November 2020.
  3. Marroni, C., Fleck, A., Fernandes, S., Galant, L., Mucenic, M., Meine, M., et al. (2018). Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World Journal of Gastroenterology, 24 (26), 2785-2805. (Level 5 evidence)
  4. OPTN. (2020, April). Organ procurement and transplantation network policies. Retrieved August 12, 2020 from